Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Journal of controlled release
| Journal of controlled release |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier |
| Soggetto topico |
Drugs - Dosage forms
Drugs - Controlled release Controlled release preparations Drugs Delayed-Action Preparations Dosage Forms Pharmaceutical Preparations Médicaments - Formes pharmaceutiques Médicaments-retard Préparations-retard Médicaments Kontrollierte Wirkstofffreisetzung Zeitschrift Online-Ressource |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1873-4995 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | CR |
| Record Nr. | UNISA-996208795003316 |
| Amsterdam ; ; New York, : Elsevier | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Journal of controlled release
| Journal of controlled release |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier |
| Soggetto topico |
Drugs - Dosage forms
Drugs - Controlled release Controlled release preparations Drugs Delayed-Action Preparations Dosage Forms Pharmaceutical Preparations Médicaments - Formes pharmaceutiques Médicaments-retard Préparations-retard Médicaments Kontrollierte Wirkstofffreisetzung Zeitschrift Online-Ressource |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1873-4995 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | CR |
| Record Nr. | UNINA-9910145764603321 |
| Amsterdam ; ; New York, : Elsevier | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910455895503321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910780602903321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.] |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
| Descrizione fisica | 1 online resource (2 volumes) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
RathboneMichael J. <1957->
HadgraftJonathan <1950-> RobertsMichael S. <1949-> LaneMajella E |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910780901203321 |
| New York : , : CRC Press, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.] |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
| Descrizione fisica | 1 online resource (2 volumes) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
RathboneMichael J. <1957->
HadgraftJonathan <1950-> RobertsMichael S. <1949-> LaneMajella E |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910800075903321 |
| New York : , : CRC Press, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910800076803321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.]
| Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, : Informa Healthcare, c2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
9781040171318
1040171311 9780429145803 0429145802 9781420044362 1420044362 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910969214503321 |
| New York, : Informa Healthcare, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-Release Drug Delivery Technology, Second Edition : Modified Release Drug Delivery Technology, Volume 2
| Modified-Release Drug Delivery Technology, Second Edition : Modified Release Drug Delivery Technology, Volume 2 |
| Autore | Rathbone Michael J |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
| Descrizione fisica | 1 online resource (727 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
HadgraftJonathan
RobertsMichael S LaneMajella E |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation�PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite�Vyteris Iontophoretic Technology""""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910455928003321 |
Rathbone Michael J
|
||
| New York : , : CRC Press, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nano-and microencapsulation for foods / / edited by Hae-Soo Kwak
| Nano-and microencapsulation for foods / / edited by Hae-Soo Kwak |
| Pubbl/distr/stampa | Chichester, England : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (438 p.) |
| Disciplina | 641.3/08 |
| Soggetto topico |
Food addititives
Microencapsulation Functional foods Controlled release preparations |
| ISBN |
1-118-29232-4
1-118-29229-4 1-118-29231-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title Page; Copyright; Contents; List of Contributors; Preface; Chapter 1 Overview of Nano- and Microencapsulation for Foods; 1.1 Introduction; 1.2 Nano- or microencapsulation as a rich source of delivery of functional components; 1.3 Wall materials used for encapsulation; 1.4 Techniques used for the production of nano- or microencapsulation of foods; 1.5 Characterization of nano- or microencapsulated functional particles; 1.6 Fortification of foods through nano- or microcapsules; 1.7 Nano- or microencapsulation technologies: industrial perspectives and applications in the food market
1.8 Overview of the bookAcknowledgments; References; Part I Concepts and rationales of nano- and microencapsulation for foods; Chapter 2 Theories and Concepts of Nano Materials, Nano- and microencapsulation; 2.1 Introduction; 2.2 Materials used for nanoparticles, nano- and microencapsulation; 2.2.1 Polymers; 2.3 Nano- and microencapsulation techniques; 2.3.1 Chemical methods; 2.3.2 Physico-chemical methods; 2.3.3 Other methods; 2.3.4 Factors influencing optimization; 2.4 Pharmaceutical and nutraceutical applications; 2.4.1 Various delivery routes for nano- and microencapsulation systems 2.5 Food ingredients and nutraceutical applications2.5.1 Background and definitions; 2.5.2 Nanomaterials, nano- and microencapsulation in nutraceuticals; 2.6 Conclusion; References; Chapter 3 Rationales of Nano- and Microencapsulation for Food Ingredients; 3.1 Introduction; 3.2 Factors affecting the quality loss of food ingredients; 3.2.1 Oxygen; 3.2.2 Light; 3.2.3 Temperature; 3.2.4 Adverse interaction; 3.2.5 Taste masking; 3.3 Case studies of food ingredient protection through nano- and microencapsulation; 3.3.1 Vitamins; 3.3.2 Enzymes; 3.3.3 Minerals; 3.3.4 Phytochemicals; 3.3.5 Lipids 3.3.6 Probiotics3.3.7 Flavors; 3.4 Conclusion; References; Chapter 4 Methodologies Used for the Characterization of Nano- and Microcapsules; 4.1 Introduction; 4.2 Methodologies used for the characterization of nano- and microcapsules; 4.2.1 Particle size and particle size distribution; 4.2.2 Zeta potential measurement; 4.2.3 Morphology; 4.2.4 Membrane flexibility; 4.2.5 Stability; 4.2.6 Encapsulation efficiency; 4.3 Conclusion; Acknowledgements; References; Chapter 5 Advanced Approaches of Nano- and Microencapsulation for Food Ingredients; 5.1 Introduction 5.2 Nanoencapsulation based on the microencapsulation technology5.3 Classification of the encapsulation system; 5.3.1 Nanoparticle or microparticle; 5.3.2 Structural encapsulation systems; 5.4 Preparation methods for the encapsulation system; 5.4.1 Emulsification; 5.4.2 Precipitation; 5.4.3 Desolvation; 5.4.4 Ionic gelation; 5.5 Application of the encapsulation system in food ingredients; 5.6 Conclusion; References; Part II Nano- and microencapsulations of food ingredients; Chapter 6 Nano- and Microencapsulation of Phytochemicals; 6.1 Introduction; 6.2 Classification of phytochemicals 6.2.1 Flavonoids |
| Record Nr. | UNINA-9910139125103321 |
| Chichester, England : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
